206 related articles for article (PubMed ID: 14615376)
1. Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.
Roberts JL; Lengi A; Brown SM; Chen M; Zhou YJ; O'Shea JJ; Buckley RH
Blood; 2004 Mar; 103(6):2009-18. PubMed ID: 14615376
[TBL] [Abstract][Full Text] [Related]
2. Eleven novel JAK3 mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain.
Mella P; Schumacher RF; Cranston T; de Saint Basile G; Savoldi G; Notarangelo LD
Hum Mutat; 2001 Oct; 18(4):355-6. PubMed ID: 11668621
[TBL] [Abstract][Full Text] [Related]
3. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency.
Roifman CM; Zhang J; Chitayat D; Sharfe N
Blood; 2000 Oct; 96(8):2803-7. PubMed ID: 11023514
[TBL] [Abstract][Full Text] [Related]
4. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
Russell SM; Tayebi N; Nakajima H; Riedy MC; Roberts JL; Aman MJ; Migone TS; Noguchi M; Markert ML; Buckley RH; O'Shea JJ; Leonard WJ
Science; 1995 Nov; 270(5237):797-800. PubMed ID: 7481768
[TBL] [Abstract][Full Text] [Related]
5. A case of aberrant CD8 T cell-restricted IL-7 signaling with a Janus kinase 3 defect-associated atypical severe combined immunodeficiency.
Khanolkar A; Wilks JD; Liu G; Simpson BM; Caparelli EA; Kirschmann DA; Bergerson J; Fuleihan RL
Immunol Res; 2020 Feb; 68(1):13-27. PubMed ID: 32215810
[TBL] [Abstract][Full Text] [Related]
6. Rapid protein-based assays for the diagnosis of T-B+ severe combined immunodeficiency.
Gilmour KC; Cranston T; Loughlin S; Gwyther J; Lester T; Espanol T; Hernandez M; Savoldi G; Davies EG; Abinun M; Kinnon C; Jones A; Gaspar HB
Br J Haematol; 2001 Mar; 112(3):671-6. PubMed ID: 11260071
[TBL] [Abstract][Full Text] [Related]
7. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.
Oakes SA; Candotti F; Johnston JA; Chen YQ; Ryan JJ; Taylor N; Liu X; Hennighausen L; Notarangelo LD; Paul WE; Blaese RM; O'Shea JJ
Immunity; 1996 Dec; 5(6):605-15. PubMed ID: 8986719
[TBL] [Abstract][Full Text] [Related]
8. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
9. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains.
Chen M; Cheng A; Candotti F; Zhou YJ; Hymel A; Fasth A; Notarangelo LD; O'Shea JJ
Mol Cell Biol; 2000 Feb; 20(3):947-56. PubMed ID: 10629052
[TBL] [Abstract][Full Text] [Related]
10. Molecular and biochemical characterization of JAK3 deficiency in a patient with severe combined immunodeficiency over 20 years after bone marrow transplantation: implications for treatment.
Bozzi F; Lefranc G; Villa A; Badolato R; Schumacher RF; Khalil G; Loiselet J; Bresciani S; O'Shea JJ; Vezzoni P; Notarangelo LD; Candotti F
Br J Haematol; 1998 Sep; 102(5):1363-6. PubMed ID: 9753072
[TBL] [Abstract][Full Text] [Related]
11. Signaling via the IL-2 and IL-7 receptors from the membrane to the nucleus.
Leonard WJ; Imada K; Nakajima H; Puel A; Soldaini E; John S
Cold Spring Harb Symp Quant Biol; 1999; 64():417-24. PubMed ID: 11232316
[No Abstract] [Full Text] [Related]
12. Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model.
Notarangelo LD; Giliani S; Mazza C; Mella P; Savoldi G; Rodriguez-Pérez C; Mazzolari E; Fiorini M; Duse M; Plebani A; Ugazio AG; Vihinen M; Candotti F; Schumacher RF
Immunol Rev; 2000 Dec; 178():39-48. PubMed ID: 11213805
[TBL] [Abstract][Full Text] [Related]
13. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
[TBL] [Abstract][Full Text] [Related]
14. Unexpected and variable phenotypes in a family with JAK3 deficiency.
Frucht DM; Gadina M; Jagadeesh GJ; Aksentijevich I; Takada K; Bleesing JJ; Nelson J; Muul LM; Perham G; Morgan G; Gerritsen EJ; Schumacher RF; Mella P; Veys PA; Fleisher TA; Kaminski ER; Notarangelo LD; O'Shea JJ; Candotti F
Genes Immun; 2001 Dec; 2(8):422-32. PubMed ID: 11781709
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional basis for JAK3-deficient severe combined immunodeficiency.
Candotti F; Oakes SA; Johnston JA; Giliani S; Schumacher RF; Mella P; Fiorini M; Ugazio AG; Badolato R; Notarangelo LD; Bozzi F; Macchi P; Strina D; Vezzoni P; Blaese RM; O'Shea JJ; Villa A
Blood; 1997 Nov; 90(10):3996-4003. PubMed ID: 9354668
[TBL] [Abstract][Full Text] [Related]
16. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction.
Saharinen P; Silvennoinen O
J Biol Chem; 2002 Dec; 277(49):47954-63. PubMed ID: 12351625
[TBL] [Abstract][Full Text] [Related]
17. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction.
Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM
J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the gene for the IL-7 receptor result in T(-)B(+)NK(+) severe combined immunodeficiency disease.
Puel A; Leonard WJ
Curr Opin Immunol; 2000 Aug; 12(4):468-73. PubMed ID: 10899029
[TBL] [Abstract][Full Text] [Related]
19. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
[TBL] [Abstract][Full Text] [Related]
20. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
